Citation Impact
Citing Papers
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
2015
Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials
2014
Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma
2015
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
Individualized treatment in stage IVC nasopharyngeal carcinoma
2014
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
2016
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Nasopharyngeal carcinoma
2019 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
2016
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
A critical review on the treatment of dye-containing wastewater: Ecotoxicological and health concerns of textile dyes and possible remediation approaches for environmental safety
2022 Standout
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
Checkpoint inhibitors in breast cancer – Current status
2017
Nasopharyngeal carcinoma
2015 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
The roles of nucleolin subcellular localization in cancer
2015
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
2018
The battle against nasopharyngeal cancer
2012
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Prognostic relevance of cancer-associated fibroblasts in human cancer
2014
Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
2021
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
2017
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)
2015
Detection of Hydrogen Peroxide with Fluorescent Dyes
2017
A critical review of biosorption of dyes, heavy metals and metalloids from wastewater as an efficient and green process
2021
Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB
2017
Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling
2017
Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
2017
Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment
2018
Interaction of tumor-associated macrophages and cancer chemotherapy
2019
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer
2015
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
2016
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
2017
Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma
2018
Heavy Metals and Pesticides Toxicity in Agricultural Soil and Plants: Ecological Risks and Human Health Implications
2021 Standout
A review on heavy metal pollution, toxicity and remedial measures: Current trends and future perspectives
2019 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer
2016
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
Works of Cong Xue being referenced
Performance and mechanisms of emerging animal-derived biochars for immobilization of heavy metals
2018
Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
2014
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib
2012
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China
2012
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
2014
Immunoregulatory effects of Taishan Pinus massoniana pollen polysaccharide on chicks co-infected with avian leukosis virus and Bordetella avium early in ovo
2014
Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma
2015
Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
2014
Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma
2012
SPARC expression and prognostic value in non-small cell lung cancer
2012
QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC
2015
Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases
2011
The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
2013
Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
2013
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
2015
A phase II study of sorafenib in combination with cisplatin and 5-fluorouracil in the treatment of recurrent or metastatic nasopharyngeal carcinoma.
2012
A ratiometric fluorescent probe for sensing hydrogen peroxide based on a hemicyanine–naphthol fluorophore
2015
High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR
2013
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer
2015